MyFinsight
Home
Blog
About
Issuance of common stock
to related party in...
$5,939K
Net cash provided by
(used in) financing...
$5,833K
(2301.13%↑ Y/Y)
Canceled cashflow
$106K
Net increase
(decrease) in cash, cash...
-$301K
(97.40%↑ Y/Y)
Canceled cashflow
$5,833K
Accrued expenses
$566K
(2730.00%↑ Y/Y)
Stock-based compensation
$313K
(-57.76%↓ Y/Y)
Depreciation
$258K
Prepaid expenses and
other assets
-$76K
(81.55%↑ Y/Y)
Non-cash lease expense
$28K
(-75.44%↓ Y/Y)
Payments on
insurancepremiumloan
-$106K
(55.27%↑ Y/Y)
Net cash used in
operating activities
-$6,035K
(46.36%↑ Y/Y)
Canceled cashflow
$1,241K
Net cash used in
investing activities
-$99K
(-30.26%↓ Y/Y)
Net loss
-$6,370K
(52.63%↑ Y/Y)
Accounts payable
-$397K
(-142.55%↓ Y/Y)
Gain on
derecognition of contract...
$335K
Accrued compensation
expenses
-$32K
(-346.15%↓ Y/Y)
R&d tax credit
incentive receivable
$12K
(-95.02%↓ Y/Y)
Purchases of property and
equipment
$99K
(30.26%↑ Y/Y)
Back
Back
Cash Flow
Vivani Medical, Inc. (VANI)
Vivani Medical, Inc. (VANI)
source: myfinsight.com